P2Y<sub>12</sub> inhibitors with oral anticoagulation for percutaneous coronary intervention with atrial fibrillation: a systematic review and meta-analysis
Florentino Lupercio(University of California San Diego), Jonathan C. Hsu(University of California San Diego), Gordon Ho(San Francisco VA Medical Center), Farshad Raissi(University of California San Diego), Ulrika Birgersdotter‐Green(University of California San Diego), Gregory K. Feld(University of California San Diego), David E. Krummen(University of California San Diego), Pedro Villablanca(Albert Einstein College of Medicine), Shaun Giancaterino(University of California San Diego), Ryan Reeves(University of California San Diego), Frederick T. Han(University of California San Diego), Kurt S. Hoffmayer(University of California San Diego), Ehtisham Mahmud(Cardiovascular Institute of the South)
Cited by 20
Related Papers
Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic
|Journal of the American College of Cardiology|2020|415
Management of Acute Myocardial Infarction During the COVID-19 Pandemic
|Journal of the American College of Cardiology|2020|395
Coronary Optical Coherence Tomography and Cardiac Magnetic Resonance Imaging to Determine Underlying Causes of Myocardial Infarction With Nonobstructive Coronary Arteries in Women
|Circulation|2020|310
Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12® rapid analyzer: The VERIfy Thrombosis risk ASsessment (VERITAS) study
|Thrombosis Research|2006|225
The Hybrid Approach to Chronic Total Occlusion Percutaneous Coronary Intervention
|JACC: Cardiovascular Interventions|2018|213